Table 1 Baseline features of two groups based on preoperative platelet counts
Variables | Whole study population | Propensity score-matched pairs | ||||
|---|---|---|---|---|---|---|
PLT < 100 (×109/L), n = 247 | PLT ≥ 100 (×109/L), n = 335 | P | PLT < 100 (×109/L), n = 201 | PLT ≥ 100 (×109/L), n = 201 | P | |
Age (years) | 51.18 ± 11.04 | 49.36 ± 11.37 | 0.054 | 50.25 ± 11.38 | 50.06 ± 12.07 | 0.872 |
Male/female | 207/40 | 288/47 | 0.482 | 173/28 | 164/37 | 0.278 |
AFP > 400 ng/mL | 76 (30.8%) | 100 (29.9%) | 0.855 | 62 (30.8%) | 63 (31.3%) | 1.000 |
TBIL (μmol/L) | 16.65 ± 6.70 | 14.33 ± 6.00 | < 0.001 | 15.61 ± 5.51 | 15.57 ± 6.71 | 0.941 |
ALB (g/L) | 41.53 ± 4.40 | 42.52 ± 5.03 | 0.014 | 42.15 ± 3.99 | 42.11 ± 4.41 | 0.921 |
ALT (IU/L) | 47.82 ± 35.86 | 47.20 ± 46.75 | 0.862 | 48.44 ± 37.47 | 45.96 ± 42.20 | 0.533 |
AST (IU/L) | 42.45 ± 25.12 | 39.48 ± 39.64 | 0.302 | 41.19 ± 25.29 | 39.38 ± 35.53 | 0.556 |
PT (s) | 12.43 ± 1.20 | 12.02 ± 1.09 | < 0.001 | 12.25 ± 1.14 | 12.17 ± 1.13 | 0.517 |
CREA (μmol/L) | 77.23 ± 24.14 | 75.94 ± 14.13 | 0.422 | 77.11 ± 15.15 | 75.60 ± 15.28 | 0.318 |
Tumor size < 3 cm | 140 (56.9%) | 160 (47.8%) | 0.036 | 106 (52.7%) | 112 (55.7%) | 0.617 |
Solitary tumor | 212 (85.8%) | 308 (91.9%) | 0.021 | 180 (89.6%) | 184 (91.5%) | 0.610 |
Transfusion (+/−) | 26/221 | 10/325 | < 0.001 | 10/191 | 10/191 | 1.000 |
Cirrhosis (+/−) | 231/16 | 270/65 | < 0.001 | 186/15 | 187/14 | 1.000 |
MVI (+/−) | 49/198 | 47/288 | 0.071 | 40/161 | 37/164 | 0.800 |
Poor differentiation | 99 (40.1%) | 113 (33.7%) | 0.117 | 84 (41.8%) | 79 (39.3%) | 0.685 |